pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-137 |
Genomic Coordinates | chr3: 118433857 - 118433929 |
Synonyms | Mirn137, mmu-mir-137, Mir137 |
Description | Mus musculus miR-137 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-137-3p |
Sequence | 45| UUAUUGCUUAAGAAUACGCGUAG |67 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Kcnk6 | ||||||||||||||||||||
Synonyms | D7Ertd764e, Toss, Twik2 | ||||||||||||||||||||
Description | potassium inwardly-rectifying channel, subfamily K, member 6 | ||||||||||||||||||||
Transcript | NM_001033525 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Kcnk6 | |||||||||||||||||||||
3'UTR of Kcnk6 (miRNA target sites are highlighted) |
>Kcnk6|NM_001033525|3'UTR 1 CTGTCGACCTGGACACACCTGGGCAGGGGCTTTGAGCCCCATGTGACTAGATCAACTGGAATGCCCAGACACACTCTCCT 81 GTCTTTTCACAGAGCTCCACTGGGAGGTGAGGAGTAGTCCCTCTGCTCCTATGTCCTCTGCTCCTCAGGGCACTGACACA 161 GTCATTTTCTCCTCCTTCCTTTTCTCCCTTTTCTTCTCAGACTCAGACCACGTGGGCTTTCTGACTTTGTTGGTGAGAGT 241 AGTGGTTTATACAATTTTTTTGTTTTGTTTTGTTCTTGTTGTTTTTCTATGTCTCGCTCTCTTGCATAGCTCATCCGGCA 321 CACCTAGTTCTTCTGGGCTCTGGGCCTGGACTCCACTTTAGCCTCTGTATTAGTGGCTTTGTCTTGGCCAAATGATTTCC 401 CCATTCTAAACCTTTATATCCCAGCCATAAGATGCAAAGAATGTTCAAACTCATCCACAGACCTTCACTTCTGCCATGCT 481 TTTCTGTGCTAGGCACACAGTAGTAGATGTGGCTTGGGCTCTGCTCTTATTGGGGTGACCAGCCAGTGAGGTAAACTGAC 561 TGACTTGCTGTCCCTTGATGGTGACAAACTCCAGTGGGCACTGGAAGAGGCAGAGTGGTCAGGACTGAGGAGTGGACCTG 641 AAATGTCCAGGTGGGCTTTCCTGGAAAACGGGACAAGAACTAACCCAAGACCTGCCAGTCAAGAGAAGAAATTCTGCCTT 721 CTTCTCAGGTGTCTATGGGCCGTAGGGCCTGTGGGAAGAGGCCTGCAAGGGGCCAGCATCTCCCTCAACGACTTAACAGG 801 CAAGGAACTGACCCAGGATATGAGCCCAGATCCAAGTGGCGTGAGAGGGGTAACTTAGCCTGGTCCTATGGTGATGCTCT 881 GTGTACCGGGGCACTGACTGATGGCCTTTCTGGGCATGCCCTGTAACTGGGCCATATTTTGCCAATGCATTTGGACAGTC 961 ACTCTACCTTTGGGACTCTGTGTCTGCTAAATGGGGAATCATAATGCTACTCCAAAAGTTGACATCAACCAGGTGCAGTA 1041 CTGGGTACCAGTAGCCTGAGCTGAAGCAGGAGGCTTGAGAGTTCAAAGGCAGGATGGGATACACAGCAGGAGCCAGGTGA 1121 TAAAATAAGCTAAGCAATATAATAATAATAATAATAATAATAATAATAATAATAATAATAATAAAATCACAGGAATATAG 1201 TGCCAAGCTAAAGGGGAGTAGGCTACAGAAGGATATACAGTCCTTGGGGTTGGAAATTACTTATACAATTGTATCACTTA 1281 AGGATTTTGACTGCAACTGACAAAAGCCAGACTGAAACAACCTGATTGTTCAATTGTAACTGGACAGAACCCGGGTGGGG 1361 AGAGACTGAGCTTGATGCTCTGCATGGCTACAGAAGGGGTGGTGGCCGTGGGTTCAGCCTCTCTTCTCCCCATAGCAGAC 1441 TTAGCTCTCATATGTGTTCTCCTCCTGGTGTCTAATGGTTGCCACAGACCCAGGCATCGAAACCAGACGTGTTATTTCTA 1521 GTGCAAGCAATAGAAACTTCAAGCAGTATTCTGAGAACTTTAAGGAAGGCTGGCTCAGTACCAAACCACTGTAGAAAGTC 1601 ACACGGGGGAACTGGGTGTGTTGGCATACAGCTACCCTAGCACTGTGGAGGGTGTGCCTGGAGAGTCCTGAGGCTAGGCT 1681 AGCCTGGGCAACCGATAATGACACCACAAAACTCCAAAGGGAGCTAGGAATGTTCACAGTGGTGGAACACGTCTGCCTCA 1761 GGTGCTAAAGAAAACAATTTACAATTATAGGTGCTGGGAAGATGGCTTAGCCAGGCAGGCTCAAAAACCTGAGTTTCTCC 1841 CCAGTCCCTACATAGAAAATGCTAGATGTCATGTCATGGTGCTGCCCTTTAATCCCAGCATCTGGAGGCAGAAGCTGGTA 1921 GAATTTCTGCGAGTTCAAGGCCAGCATGGTCTACTTAGTGAGTTTGAGGACAATTAGGGCTACATAGTAAGACCCTGCAT 2001 CCACAAAATAACTAAAAACTAAAAATAGTGTGACAAGTGATTAGGAAAAAAGTAGATATTAAACTCTAGCTTCCATGTGT 2081 AAACTCACACACACTTAAAAGTCTGAGGCAGCAAAATATTTTTTTGGCGGGGGGCTGGTTTCAAGACAGGGTTTCTCTAT 2161 GTAGCCCTGGCTATCCTGGAACTCACTTTGTAGACCAGGCTGGCCTTGAACTCAGAAATCTGCCTGCCTCTGCTTCCTAA 2241 GTGCTGGGATTAAAGGTATGCACCACCACACCCGGCTTCATAATGAGTTATTTCTCTACCAGTGAAATGAGTCAGTTCAA 2321 GCCAGCTTGGATTATATTGAAGGCAGGTTTATTGGGAAACTGGCCTTGGTTGAGTTCACTGGCCCCAAGGATTGAGCCCA 2401 GGGGAATTGCCATTGGAGGTGGTATGGGGAGAAAAGACACATGTGCACACATACACAGGGGGAAAGACAGATGTCTGAAT 2481 TATATAGGGAGGAGCCTGGGGGGGGGGGGGAGAACAGCCCAGCCCCTGAGCTAAAAAGTTCAAGCTTGGGGTCAGGATAT 2561 GTCAGGTAGGGACTGAGGGATGCTGGGAGAACCTGGAGGCCAGGTCTGCTCTGATATGTAAAATGCATACCTCAATCCCT 2641 TGTCCCAGGGTCCAAAACCAAAGTACCCAAAGTACAATTGATTTCTCAAGTCTTTATCTGCATATAGGCTATGCACGAAC 2721 TAGCAATATGTGGATGTGCATATGTGTGAGTCTTCCACCCTACACAAAGGTTACCAGCAATGGGAAGTGATGACTATTCC 2801 TGGTTCTGAAAGCAGAACTCTGTGAGTTTGAACCCTTGTCCTTGTATTTCACTTGTGCCTCAGATTGCTTATTTATGAAA 2881 GGGTATTTGTACAGCACTACCTCGTGGACTGGAACACCCAGCCGTCTAATGCTTGTAACTCTTACCCTACAGCACCATCA 2961 GGGAGTCAATAAAGTGCCTGACCCGTCCCTCGATCTGAACTCTGTTCTTAGCAAGGAAGGTCACGTAAAATAGAAATGCG 3041 TGACTTTTGGGATAGCATTGGAAATGTAAATGAAGAAAATACCTAATTAAAAAAAAAAAGAAATGCGT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C2C12 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1385342. RNA binding protein: 聽AGO2. Condition:C2C12_GM_Ago2_CLIP-Seq_myoblast
... - Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al., 2014, Cell. |
Article |
- Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al. - Cell, 2014
MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immunoprecipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.
LinkOut: [PMID: 25083871]
|
16 mmu-miR-137-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT000452 | Ezh2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 4 | 1 | ||||||||
MIRT001015 | CDK6 | cyclin dependent kinase 6 | 3 | 1 | ||||||||
MIRT005501 | Tbx3 | T-box 3 | 3 | 1 | ||||||||
MIRT006933 | Nf1 | neurofibromin 1 | 1 | 1 | ||||||||
MIRT014840 | Cdk6 | cyclin-dependent kinase 6 | 1 | 1 | ||||||||
MIRT438758 | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 | 2 | 1 | ||||||||
MIRT580289 | Trhr | thyrotropin releasing hormone receptor | 1 | 1 | ||||||||
MIRT581519 | Ptprd | protein tyrosine phosphatase, receptor type, D | 1 | 1 | ||||||||
MIRT585929 | Slc16a9 | solute carrier family 16 (monocarboxylic acid transporters), member 9 | 1 | 1 | ||||||||
MIRT586765 | Kcnk6 | potassium inwardly-rectifying channel, subfamily K, member 6 | 1 | 1 | ||||||||
MIRT593788 | Ncf2 | neutrophil cytosolic factor 2 | 1 | 1 | ||||||||
MIRT594208 | Wdr12 | WD repeat domain 12 | 1 | 1 | ||||||||
MIRT595898 | Cd69 | CD69 antigen | 1 | 1 | ||||||||
MIRT596006 | Diras2 | DIRAS family, GTP-binding RAS-like 2 | 1 | 1 | ||||||||
MIRT597415 | Rpp40 | ribonuclease P 40 subunit | 1 | 1 | ||||||||
MIRT604053 | Esf1 | ESF1 nucleolar pre-rRNA processing protein homolog | 1 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|